Nilotinib‐Induced Retinal Artery Thrombosis in a Patient With Chronic Myeloid Leukaemia: A Rare Case
This case underlines the importance of considering rare but severe arterio-occlusive complications, such as retinal artery thrombosis, among the cardiovascular toxicities of nilotinib. Careful cardiovascular monitoring and early recognition of such events are crucial to optimize patient safety and treatment outcomes in CML management.
Authors
- Nazanin Alemzadeh
- Abolfazl Khalafi‐Nezhad (ORCID: https://orcid.org/0000-0001-8762-9837)
- Zahra Ghanbarinasab
- Bijan Najafi (ORCID: https://orcid.org/0009-0004-4779-6971)
- Vahid Mohammadkarimi
- Reza Vahid
Institutions
- Shiraz University of Medical Sciences (IR)
Publication Details
- Journal
- Cancer Reports
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/cnr2.70501
- Citations
- 1
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 35.41